{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:07:38Z","timestamp":1791544058289,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s40263-021-00801-4","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T02:05:26Z","timestamp":1615601126000},"page":"461-468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4192-853X","authenticated-orcid":false,"given":"Olivier","family":"Corbeil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Corbeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Dorval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Hugues","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Giroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Demers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,13]]},"reference":[{"key":"801_CR1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.addbeh.2013.11.005","volume":"39","author":"L Gaboriau","year":"2014","unstructured":"Gaboriau L, Victorri-Vigneau C, G\u00e9rardin M, Allain-Veyrac G, Jolliet-Evin P, Grall-Bronnec M. Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports. Addict Behav. 2014;39:562\u20135.","journal-title":"Addict Behav."},{"key":"801_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.physbeh.2011.04.055","volume":"104","author":"JE Ahlskog","year":"2011","unstructured":"Ahlskog JE. Pathological behaviors provoked by dopamine agonist therapy of Parkinson\u2019s disease. Physiol Behav. 2011;104:168\u201372.","journal-title":"Physiol Behav."},{"key":"801_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2165\/00023210-200822050-00004","volume":"22","author":"M Lader","year":"2008","unstructured":"Lader M. Antiparkinsonian medication and pathological gambling. CNS Drugs. 2008;22:407\u201316.","journal-title":"CNS Drugs"},{"key":"801_CR4","doi-asserted-by":"publisher","first-page":"728038","DOI":"10.1155\/2014\/728038","volume":"2014","author":"D Pirritano","year":"2014","unstructured":"Pirritano D, Plastino M, Bosco D, Gallelli L, Siniscalchi A, De Sarro G. Gambling disorder during dopamine replacement treatment in Parkinson\u2019s disease: a comprehensive review. Biomed Res Int. 2014;2014:728038.","journal-title":"Biomed Res Int."},{"key":"801_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2174\/157488612800492726","volume":"7","author":"M Raja","year":"2012","unstructured":"Raja M, Bentivoglio AR. Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson\u2019s disease and other disorders. Curr Drug Saf. 2012;7:63\u201375.","journal-title":"Curr Drug Saf."},{"key":"801_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1212\/CPJ.0b013e318278be9b","volume":"2","author":"HD Weiss","year":"2012","unstructured":"Weiss HD, Marsh L. Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease. Neurol Clin Pract. 2012;2:267\u201374.","journal-title":"Neurol Clin Pract."},{"key":"801_CR7","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","volume":"174","author":"TJ Moore","year":"2014","unstructured":"Moore TJ, Glenmullen J, Mattison DR. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med. 2014;174:1930\u20133.","journal-title":"JAMA Intern Med."},{"key":"801_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/YIC.0000000000000194","volume":"33","author":"U Lertxundi","year":"2018","unstructured":"Lertxundi U, Hernandez R, Medrano J, Domingo-Echaburu S, Garcia M, Aguirre C. Aripiprazole and impulse control disorders: higher risk with the intramuscular depot formulation? Int Clin Psychopharmacol. 2018;33:56\u20138.","journal-title":"Int Clin Psychopharmacol."},{"key":"801_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/JCP.0000000000000634","volume":"37","author":"M Etminan","year":"2017","unstructured":"Etminan M, Sodhi M, Samii A, Procyshyn RM, Guo M, Carleton BC. Risk of gambling disorder and impulse control disorder with aripiprazole, pramipexole, and ropinirole: a pharmacoepidemiologic study. J Clin Psychopharmacol. 2017;37:102\u20134.","journal-title":"J Clin Psychopharmacol."},{"key":"801_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10899-014-9471-4","volume":"31","author":"JW Welte","year":"2015","unstructured":"Welte JW, Barnes GM, Tidwell MC, Hoffman JH, Wieczorek WF. Gambling and problem gambling in the United States: changes between 1999 and 2013. J Gambl Stud. 2015;31:695\u2013715.","journal-title":"J Gambl Stud."},{"key":"801_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","volume":"17","author":"AA Grace","year":"2016","unstructured":"Grace AA. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci. 2016;17:524\u201332.","journal-title":"Nat Rev Neurosci."},{"key":"801_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biopsych.2016.07.014","volume":"81","author":"OD Howes","year":"2017","unstructured":"Howes OD, McCutcheon R, Owen MJ, Murray RM. The role of genes, stress, and dopamine in the development of schizophrenia. Biol Psychiatry. 2017;81:9\u201320.","journal-title":"Biol Psychiatry."},{"key":"801_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/JCP.0000000000001068","volume":"39","author":"A Lachance","year":"2019","unstructured":"Lachance A, Corbeil O, Corbeil S, Chalifour G, Breault AS, Roy MA, et al. Case reports of aripiprazole and problematic gambling in schizophrenia: a critical review of the evidence. J Clin Psychopharmacol. 2019;39:393\u20137.","journal-title":"J Clin Psychopharmacol."},{"key":"801_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1556\/2006.7.2018.47","volume":"7","author":"A Bergamini","year":"2018","unstructured":"Bergamini A, Turrina C, Bettini F, Toccagni A, Valsecchi P, Sacchetti E, et al. At-risk gambling in patients with severe mental illness: prevalence and associated features. J Behav Addict. 2018;7:348\u201354.","journal-title":"J Behav Addict."},{"key":"801_CR15","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.4088\/JCP.m04359","volume":"70","author":"RA Desai","year":"2009","unstructured":"Desai RA, Potenza MN. A cross-sectional study of problem and pathological gambling in patients with schizophrenia\/schizoaffective disorder. J Clin Psychiatry. 2009;70:1250\u20137.","journal-title":"J Clin Psychiatry."},{"key":"801_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.comppsych.2015.01.003","volume":"58","author":"M Haydock","year":"2015","unstructured":"Haydock M, Cowlishaw S, Harvey C, Castle D. Prevalence and correlates of problem gambling in people with psychotic disorders. Compr Psychiatry. 2015;58:122\u20139.","journal-title":"Compr Psychiatry."},{"key":"801_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.schres.2017.06.039","volume":"194","author":"MF Brunette","year":"2018","unstructured":"Brunette MF, Mueser KT, Babbin S, Meyer-Kalos P, Rosenheck R, Correll CU, et al. Demographic and clinical correlates of substance use disorders in first episode psychosis. Schizophr Res. 2018;194:4\u201312.","journal-title":"Schizophr Res."},{"key":"801_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10899-008-9088-6","volume":"25","author":"A Johansson","year":"2009","unstructured":"Johansson A, Grant JE, Kim SW, Odlaug BL, G\u00f6testam KG. Risk factors for problematic gambling: a critical literature review. J Gambl Stud. 2009;25:67\u201392.","journal-title":"J Gambl Stud."},{"key":"801_CR19","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1017\/S0033291707002036","volume":"38","author":"G Newton-Howes","year":"2008","unstructured":"Newton-Howes G, Tyrer P, North B, Yang M. The prevalence of personality disorder in schizophrenia and psychotic disorders: systematic review of rates and explanatory modelling. Psychol Med. 2008;38:1075\u201382.","journal-title":"Psychol Med."},{"key":"801_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/pmh.49","volume":"2","author":"E Simonsen","year":"2008","unstructured":"Simonsen E, Haahr U, Mortensen EL, Friis S, Johannessen JO, Larsen TK, et al. Personality disorders in first-episode psychosis. Pers Ment Health. 2008;2:230\u20139.","journal-title":"Pers Ment Health."},{"key":"801_CR21","unstructured":"Ferris J, Wynne H. The Canadian Problem Gambling Index: final report. Ottawa, ON: Canadian Centre on Substance Abuse; 2001."},{"key":"801_CR22","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Arlington: American Psychiatric Publishing; 2013."},{"key":"801_CR23","volume-title":"Problem gambling and harm: towards a national definition","author":"P Neal","year":"2005","unstructured":"Neal P, Delfabbro P, O\u2019Neil M. Problem gambling and harm: towards a national definition. Melbourne: Gambling Research Australia; 2005."},{"key":"801_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/JCP.0000000000001177","volume":"40","author":"O Corbeil","year":"2020","unstructured":"Corbeil O, Corbeil S, Giroux I, Jacques C, Dorval M, Demers MF, et al. Problem gambling associated with aripiprazole in first-episode psychosis patients: a series of 6 case reports. J Clin Psychopharmacol. 2020;40:191\u20134.","journal-title":"J Clin Psychopharmacol."},{"key":"801_CR25","volume-title":"Improving the psychometric properties of the Problem Gambling Severity Index","author":"SR Currie","year":"2010","unstructured":"Currie SR, Casey DM, Hodgins DC. Improving the psychometric properties of the Problem Gambling Severity Index. Ottawa: Canadian Consortium for Gambling Research; 2010."},{"key":"801_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/14459790600928678","volume":"6","author":"MW Abbott","year":"2006","unstructured":"Abbott MW, Volberg RA. The measurement of adult problem and pathological gambling. Int Gambl Stud. 2006;6:175\u2013200.","journal-title":"Int Gambl Stud."},{"key":"801_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40429-016-0118-7","volume":"3","author":"K Caler","year":"2016","unstructured":"Caler K, Garcia JRV, Nower L. Assessing problem gambling: a review of classic and specialized measures. Curr Addict Rep. 2016;3:437\u201344.","journal-title":"Curr Addict Rep."},{"key":"801_CR28","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4:28\u201337.","journal-title":"Psychiatry (Edgmont)."},{"key":"801_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/9781118548387","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2013","unstructured":"Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. New York: Wiley; 2013."},{"key":"801_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ajp.2016.08.001","volume":"23","author":"A Mahapatra","year":"2016","unstructured":"Mahapatra A, Sharma P, Sagar R. Aripiprazole induced impulse control disorders: where do we stand? Asian J Psychiatr. 2016;23:128\u201330.","journal-title":"Asian J Psychiatr."},{"key":"801_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/14459795.2016.1209780","volume":"16","author":"C Luce","year":"2016","unstructured":"Luce C, Nadeau L, Kairouz S. Pathways and transitions of gamblers over 2 years. Int Gambl Stud. 2016;16:357\u201372.","journal-title":"Int Gambl Stud."},{"key":"801_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1017\/thg.2019.90","volume":"22","author":"TM Piasecki","year":"2019","unstructured":"Piasecki TM, Gizer IR, Slutske WS. Polygenic risk scores for psychiatric disorders reveal novel clues about the genetics of disordered gambling. Twin Res Hum Genet. 2019;22:283\u20139.","journal-title":"Twin Res Hum Genet."},{"key":"801_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1521\/pedi_2014_28_168","volume":"29","author":"NA Dowling","year":"2015","unstructured":"Dowling NA, Cowlishaw S, Jackson AC, Merkouris SS, Francis KL, Christensen DR. The prevalence of comorbid personality disorders in treatment-seeking problem gamblers: a systematic review and meta-analysis. J Pers Disord. 2015;29:735\u201354.","journal-title":"J Pers Disord."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-021-00801-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-021-00801-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-021-00801-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T02:57:24Z","timestamp":1619319444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-021-00801-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,13]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1007\/s40263-021-00801-4","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,13]]},"assertion":[{"value":"28 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors did not receive any funding for the research, authorship and publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Olivier Corbeil has received an honorarium from Janssen and Otsuka-Lundbeck Alliance and is currently receiving a grant from the Fonds de Recherche du Qu\u00e9bec-Sant\u00e9. Marie-France Demers has received grants from Janssen and Otsuka-Lundbeck Alliance. Marc-Andr\u00e9 Roy has received grants from Otsuka-Lundbeck Alliance, Janssen, Sunovion and Mylan. All other authors have no conflicts of interest that are directly relevant to the content of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"All data generated or analysed during this study are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Olivier Corbeil and St\u00e9phanie Corbeil conceptualized the research question and study design, collected the data, interpreted the results and wrote the first draft of the manuscript. Pierre-Hugues Carmichael conducted the analyses and interpreted the results. Michel Dorval, Isabelle Giroux and Christian Jacques conceptualized the research question and study design. Marie-France Demers and Marc-Andr\u00e9 Roy interpreted the results and supervised the project. All authors critically revised the manuscript and approved the final manuscript that was submitted.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Study protocol was reviewed and approved by the institution\u2019s ethics board and access to patients\u2019 medical files was granted by the professional services\u2019 director. No signed consent was requested, as data collection did not require contact with patients. All research data were anonymized.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors would like to thank Guillaume Chalifour and Ann-Sophie Breault for their support in designing the study as well as Marie-Pier Ducas, Anne-Marie Essiambre, Alexandre Lachance and Chantal Valli\u00e8res for their help during data collection. Authors also wish to thank Catherine Boudreault for her contribution in the case identification procedure as well as the entire staff at the Clinique Notre-Dame des Victoires for their precious collaboration and their unwavering dedication to patients\u2019 recovery.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}}]}}